Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 207.12
+4.22 (2.08%)
Mar 14, 2025, 1:45 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.80B CNY in the quarter ending September 30, 2024, with 9.60% growth. This brings the company's revenue in the last twelve months to 10.91B, up 12.72% year-over-year. In the year 2023, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.06B with 15.69% growth.
Revenue (ttm)
10.91B
Revenue Growth
+12.72%
P/S Ratio
11.23
Revenue / Employee
3.91M
Employees
2,789
Market Cap
122.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
| Dec 31, 2019 | 5.72B | 956.12M | 20.06% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |